Stay updated with breaking news from Translational Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Structure Therapeutics announced that the Company will present three scientific posters at the upcoming 2023 American Thoracic Society (ATS) International Conference.
Posters include data across biomarker, translation and clinical studies supportingdevelopment of bexotegrast , a dual-selective inhibitor of αvβ6/αvβ1 integrins, in IPF Two... | March 27, 2023
Posters include data across biomarker, translation and clinical studies supportingdevelopment of bexotegrast (PLN-74809), a dual-selective inhibitor of...